{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:19:24Z","timestamp":1792783164048,"version":"4.5.0"},"reference-count":208,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This study was funded by Iran National Sciences Foundation (INSF)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s11033-023-08859-7","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T21:02:01Z","timestamp":1697576521000},"page":"10409-10425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Kynurenine pathway and its role in neurologic, psychiatric, and inflammatory bowel diseases"],"prefix":"10.1007","volume":"50","author":[{"given":"Mohammad","family":"Sheibani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Shayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Khalilzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra Ebrahim","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Jafari-Sabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1384-9826","authenticated-orcid":false,"given":"Mehdi","family":"Ghasemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,18]]},"reference":[{"key":"8859_CR1","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.3390\/cells10061548","volume":"10","author":"MN Mithaiwala","year":"2021","unstructured":"Mithaiwala MN, Santana-Coelho D, Porter GA, O\u2019Connor JC (2021) Neuroinflammation and the kynurenine pathway in CNS disease: molecular mechanisms and therapeutic implications. Cells 10:1548","journal-title":"Cells"},{"key":"8859_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41380-019-0414-4","volume":"25","author":"J Savitz","year":"2020","unstructured":"Savitz J (2020) The kynurenine pathway: a finger in every pie. Mol Psychiatry 25:131\u2013147","journal-title":"Mol Psychiatry"},{"key":"8859_CR3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/1567202054368326","volume":"2","author":"H Nemeth","year":"2005","unstructured":"Nemeth H, Toldi J, V\u00e9csei L (2005) Role of kynurenines in the central and peripherial nervous systems. Curr Neurovasc Res 2:249\u2013260","journal-title":"Curr Neurovasc Res"},{"issue":"2","key":"8859_CR4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/mr\/roac016","volume":"33","author":"D Tezcan","year":"2023","unstructured":"Tezcan D, Onmaz DE, Sivrikaya A, K\u00f6rez MK, Hakbilen S, G\u00fclcemal S, Y\u0131lmaz S (2023) Kynurenine pathway of tryptophan metabolism in patients with familial Mediterranean fever. Mod Rheumatol 33(2):398\u2013407","journal-title":"Mod Rheumatol"},{"key":"8859_CR5","doi-asserted-by":"publisher","first-page":"107807","DOI":"10.1016\/j.pharmthera.2021.107807","volume":"223","author":"N Morales-Puerto","year":"2021","unstructured":"Morales-Puerto N, Gim\u00e9nez-G\u00f3mez P, P\u00e9rez-Hern\u00e1ndez M, Abuin-Mart\u00ednez C, de Biedma-Elduayen LG, Vidal R, Guti\u00e9rrez-L\u00f3pez MD, O\u2019Shea E, Colado MI (2021) Addiction and the kynurenine pathway: a new dancing couple? Pharmacol Ther 223:107807","journal-title":"Pharmacol Ther"},{"key":"8859_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s40495-019-00208-2","volume":"6","author":"A Tutakhail","year":"2020","unstructured":"Tutakhail A, Boulet L, Khabil S, Nazari QA, Hamid H, Coudor\u00e9 F (2020) Neuropathology of kynurenine pathway of tryptophan metabolism. Curr Pharmacol Rep 6:8\u201323","journal-title":"Curr Pharmacol Rep"},{"key":"8859_CR7","doi-asserted-by":"publisher","first-page":"110145","DOI":"10.1016\/j.pnpbp.2020.110145","volume":"106","author":"M Wi\u0119d\u0142ocha","year":"2021","unstructured":"Wi\u0119d\u0142ocha M, Marcinowicz P, Janoska-Ja\u017adzik M, Szulc A (2021) Gut microbiota, kynurenine pathway and mental disorders\u2014review. Prog Neuropsychopharmacol Biol Psychiatry 106:110145","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8859_CR8","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/s41575-019-0259-y","volume":"17","author":"A Mikocka-Walus","year":"2020","unstructured":"Mikocka-Walus A, Ford AC, Drossman DA (2020) Antidepressants in inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 17:184\u2013192","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"8859_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-021-02175-2","volume":"18","author":"L-M Chen","year":"2021","unstructured":"Chen L-M, Bao C-H, Wu Y, Liang S-H, Wang D, Wu L-Y, Huang Y, Liu H-R, Wu H-G (2021) Tryptophan-kynurenine metabolism: a link between the gut and brain for depression in inflammatory bowel disease. J Neuroinflamm 18:1\u201313","journal-title":"J Neuroinflamm"},{"key":"8859_CR10","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1093\/ibd\/izy103","volume":"24","author":"MA Sofia","year":"2018","unstructured":"Sofia MA, Ciorba MA, Meckel K, Lim CK, Guillemin GJ, Weber CR, Bissonnette M, Pekow JR (2018) Tryptophan metabolism through the kynurenine pathway is associated with endoscopic inflammation in ulcerative colitis. Inflamm Bowel Dis 24:1471\u20131480","journal-title":"Inflamm Bowel Dis"},{"key":"8859_CR11","doi-asserted-by":"publisher","first-page":"13497","DOI":"10.3390\/ijms222413497","volume":"22","author":"A Wnorowski","year":"2021","unstructured":"Wnorowski A, Wnorowska S, Kurzepa J, Parada-Turska J (2021) Alterations in kynurenine and NAD+ salvage pathways during the successful treatment of inflammatory bowel disease suggest HCAR3 and NNMT as potential drug targets. Int J Mol Sci 22:13497","journal-title":"Int J Mol Sci"},{"key":"8859_CR12","first-page":"203","volume":"28","author":"M Carabotti","year":"2015","unstructured":"Carabotti M, Scirocco A, Maselli MA, Severi C (2015) The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems. Ann Gastroenterol 28:203","journal-title":"Ann Gastroenterol"},{"key":"8859_CR13","doi-asserted-by":"publisher","first-page":"175628481988130","DOI":"10.1177\/1756284819881304","volume":"12","author":"E Dudzi\u0144ska","year":"2019","unstructured":"Dudzi\u0144ska E, Szymona K, Kloc R, Gil-Kulik P, Kocki T, \u015awistowska M, Bogucki J, Kocki J, Urbanska EM (2019) Increased expression of kynurenine aminotransferases mRNA in lymphocytes of patients with inflammatory bowel disease. Ther Adv Gastroenterol 12:1756284819881304","journal-title":"Ther Adv Gastroenterol"},{"key":"8859_CR14","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/ecco-jcc\/jjab162","volume":"16","author":"GH Kim","year":"2022","unstructured":"Kim GH, Lee YC, Kim TJ, Kim ER, Hong SN, Chang DK, Kim Y-H (2022) Risk of neurodegenerative diseases in patients with inflammatory bowel disease: a nationwide population-based cohort study. J Crohns Colitis 16:436\u2013443","journal-title":"J Crohns Colitis"},{"key":"8859_CR15","doi-asserted-by":"publisher","unstructured":"Ball HJ, Sanchez-Perez A, Weiser S et al (2007) Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene 396:203\u2013213. https:\/\/doi.org\/10.1016\/j.gene.2007.04.010","DOI":"10.1016\/j.gene.2007.04.010"},{"key":"8859_CR16","doi-asserted-by":"publisher","first-page":"10910","DOI":"10.1021\/bi201439m","volume":"50","author":"L Capece","year":"2011","unstructured":"Capece L, Lewis-Ballester A, Marti MA, Estrin DA, Yeh SR (2011) Molecular basis for the substrate stereoselectivity in tryptophan dioxygenase. Biochemistry 50:10910\u201310918. https:\/\/doi.org\/10.1021\/bi201439m","journal-title":"Biochemistry"},{"key":"8859_CR17","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1016\/j.biocel.2007.01.004","volume":"39","author":"NJ King","year":"2007","unstructured":"King NJ, Thomas SR (2007) Molecules in focus: indoleamine 2,3-dioxygenase. Int J Biochem Cell Biol 39:2167\u20132172. https:\/\/doi.org\/10.1016\/j.biocel.2007.01.004","journal-title":"Int J Biochem Cell Biol"},{"key":"8859_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1756-6606-2-8","volume":"2","author":"M Kanai","year":"2009","unstructured":"Kanai M, Funakoshi H, Takahashi H, Hayakawa T, Mizuno S, Matsumoto K, Nakamura T (2009) Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice. Mol Brain 2:8. https:\/\/doi.org\/10.1186\/1756-6606-2-8","journal-title":"Mol Brain"},{"key":"8859_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4137\/IJTR.S4372","volume":"3","author":"M Kanai","year":"2010","unstructured":"Kanai M, Funakoshi H, Nakamura T (2010) Implication of tryptophan 2,3-dioxygenase and its novel variants in the hippocampus and cerebellum during the developing and adult brain. Int J Tryptophan Res 3:141\u2013149","journal-title":"Int J Tryptophan Res"},{"key":"8859_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1756-6606-1-6","volume":"1","author":"N Yamasaki","year":"2008","unstructured":"Yamasaki N, Maekawa M, Kobayashi K et al (2008) Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders. Mol Brain 1:6. https:\/\/doi.org\/10.1186\/1756-6606-1-6","journal-title":"Mol Brain"},{"key":"8859_CR21","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1073\/pnas.1113873109","volume":"109","author":"L Pilotte","year":"2012","unstructured":"Pilotte L, Larrieu P, Stroobant V et al (2012) Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase. Proc Natl Acad Sci USA 109:2497\u20132502. https:\/\/doi.org\/10.1073\/pnas.1113873109","journal-title":"Proc Natl Acad Sci USA"},{"key":"8859_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1186\/s12891-022-05567-4","volume":"23","author":"G Rong","year":"2022","unstructured":"Rong G, Zhang T, Xu Y, Zhang Z, Gui B, Hu K, Zhang J, Tang Z, Shen C (2022) High levels of TDO2 in relation to pro-inflammatory cytokines in synovium and synovial fluid of patients with osteoarthritis. BMC Musculoskelet Disord 23:604. https:\/\/doi.org\/10.1186\/s12891-022-05567-4","journal-title":"BMC Musculoskelet Disord"},{"key":"8859_CR23","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nri1457","volume":"4","author":"AL Mellor","year":"2004","unstructured":"Mellor AL, Munn DH (2004) IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 4:762\u2013774. https:\/\/doi.org\/10.1038\/nri1457","journal-title":"Nat Rev Immunol"},{"key":"8859_CR24","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/j.febslet.2007.02.073","volume":"581","author":"ID Jung","year":"2007","unstructured":"Jung ID, Lee CM, Jeong YI, Lee JS, Park WS, Han J, Park YM (2007) Differential regulation of indoleamine 2,3-dioxygenase by lipopolysaccharide and interferon gamma in murine bone marrow derived dendritic cells. FEBS Lett 581:1449\u20131456. https:\/\/doi.org\/10.1016\/j.febslet.2007.02.073","journal-title":"FEBS Lett"},{"key":"8859_CR25","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1046\/j.1471-4159.1996.66030996.x","volume":"66","author":"D Alberati-Giani","year":"1996","unstructured":"Alberati-Giani D, Ricciardi-Castagnoli P, K\u00f6hler C, Cesura AM (1996) Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells. J Neurochem 66:996\u20131004. https:\/\/doi.org\/10.1046\/j.1471-4159.1996.66030996.x","journal-title":"J Neurochem"},{"key":"8859_CR26","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.immuni.2022.05.013","volume":"55","author":"M Gargaro","year":"2022","unstructured":"Gargaro M, Scalisi G, Manni G et al (2022) Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication. Immunity 55:1032-1050.e1014. https:\/\/doi.org\/10.1016\/j.immuni.2022.05.013","journal-title":"Immunity"},{"key":"8859_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1369\/jhc.2009.953604","volume":"58","author":"X Dai","year":"2010","unstructured":"Dai X, Zhu BT (2010) Indoleamine 2,3-dioxygenase tissue distribution and cellular localization in mice: implications for its biological functions. J Histochem Cytochem 58:17\u201328. https:\/\/doi.org\/10.1369\/jhc.2009.953604","journal-title":"J Histochem Cytochem"},{"key":"8859_CR28","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/cas.12445","volume":"105","author":"Y Tanizaki","year":"2014","unstructured":"Tanizaki Y, Kobayashi A, Toujima S et al (2014) Indoleamine 2,3-dioxygenase promotes peritoneal metastasis of ovarian cancer by inducing an immunosuppressive environment. Cancer Sci 105:966\u2013973. https:\/\/doi.org\/10.1111\/cas.12445","journal-title":"Cancer Sci"},{"key":"8859_CR29","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1056\/NEJMoa035075","volume":"349","author":"JM Kremer","year":"2003","unstructured":"Kremer JM, Westhovens R, Leon M et al (2003) Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 349:1907\u20131915. https:\/\/doi.org\/10.1056\/NEJMoa035075","journal-title":"N Engl J Med"},{"key":"8859_CR30","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1172\/jci61884","volume":"122","author":"H Kim","year":"2012","unstructured":"Kim H, Chen L, Lim G et al (2012) Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. J Clin Invest 122:2940\u20132954. https:\/\/doi.org\/10.1172\/jci61884","journal-title":"J Clin Invest"},{"key":"8859_CR31","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00726-022-03170-4","volume":"54","author":"D Eryavuz Onmaz","year":"2022","unstructured":"Eryavuz Onmaz D, Tezcan D, Abusoglu S, Sivrikaya A, Kuzu M, Yerlikaya FH, Yilmaz S, Unlu A (2022) Elevated serum levels of kynurenine pathway metabolites in patients with Beh\u00e7et disease. Amino Acids 54:877\u2013887. https:\/\/doi.org\/10.1007\/s00726-022-03170-4","journal-title":"Amino Acids"},{"key":"8859_CR32","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3389\/fimmu.2014.00585","volume":"5","author":"GC Prendergast","year":"2014","unstructured":"Prendergast GC, Metz R, Muller AJ, Merlo LM, Mandik-Nayak L (2014) IDO2 in Immunomodulation and Autoimmune Disease. Front Immunol 5:585. https:\/\/doi.org\/10.3389\/fimmu.2014.00585","journal-title":"Front Immunol"},{"key":"8859_CR33","doi-asserted-by":"publisher","first-page":"7082","DOI":"10.1158\/0008-5472.can-07-1872","volume":"67","author":"R Metz","year":"2007","unstructured":"Metz R, Duhadaway JB, Kamasani U, Laury-Kleintop L, Muller AJ, Prendergast GC (2007) Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res 67:7082\u20137087. https:\/\/doi.org\/10.1158\/0008-5472.can-07-1872","journal-title":"Cancer Res"},{"key":"8859_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s13566-013-0111-x","volume":"2","author":"HB Eldredge","year":"2013","unstructured":"Eldredge HB, DeNittis A, DuHadaway JB, Chernick M, Metz R, Prendergast GC (2013) Concurrent whole brain radiotherapy and short-course chloroquine in patients with brain metastases: a pilot trial. J Radiat Oncol 2:315\u2013321. https:\/\/doi.org\/10.1007\/s13566-013-0111-x","journal-title":"J Radiat Oncol"},{"key":"8859_CR35","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1177\/0269881111434622","volume":"26","author":"JA Cutler","year":"2012","unstructured":"Cutler JA, Rush AJ, McMahon FJ, Laje G (2012) Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder. J Psychopharmacol 26:360\u2013367. https:\/\/doi.org\/10.1177\/0269881111434622","journal-title":"J Psychopharmacol"},{"key":"8859_CR36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0014-2999(88)90367-6","volume":"154","author":"PJ Birch","year":"1988","unstructured":"Birch PJ, Grossman CJ, Hayes AG (1988) Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor. Eur J Pharmacol 154:85\u201387. https:\/\/doi.org\/10.1016\/0014-2999(88)90367-6","journal-title":"Eur J Pharmacol"},{"key":"8859_CR37","doi-asserted-by":"publisher","first-page":"7463","DOI":"10.1523\/jneurosci.21-19-07463.2001","volume":"21","author":"C Hilmas","year":"2001","unstructured":"Hilmas C, Pereira EF, Alkondon M, Rassoulpour A, Schwarcz R, Albuquerque EX (2001) The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J Neurosci 21:7463\u20137473. https:\/\/doi.org\/10.1523\/jneurosci.21-19-07463.2001","journal-title":"J Neurosci"},{"key":"8859_CR38","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1097\/00001756-199711100-00039","volume":"8","author":"R Kapoor","year":"1997","unstructured":"Kapoor R, Okuno E, Kido R, Kapoor V (1997) Immuno-localization of kynurenine aminotransferase (KAT) in the rat medulla and spinal cord. NeuroReport 8:3619\u20133623. https:\/\/doi.org\/10.1097\/00001756-199711100-00039","journal-title":"NeuroReport"},{"key":"8859_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00702-011-0763-x","volume":"119","author":"F Moroni","year":"2012","unstructured":"Moroni F, Cozzi A, Sili M, Mannaioni G (2012) Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery. J Neural Transm (Vienna) 119:133\u2013139. https:\/\/doi.org\/10.1007\/s00702-011-0763-x","journal-title":"J Neural Transm (Vienna)"},{"key":"8859_CR40","doi-asserted-by":"publisher","first-page":"22021","DOI":"10.1074\/jbc.M603503200","volume":"281","author":"J Wang","year":"2006","unstructured":"Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, Ling L (2006) Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem 281:22021\u201322028. https:\/\/doi.org\/10.1074\/jbc.M603503200","journal-title":"J Biol Chem"},{"key":"8859_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.neubiorev.2018.03.023","volume":"90","author":"K Ogyu","year":"2018","unstructured":"Ogyu K, Kubo K, Noda Y et al (2018) Kynurenine pathway in depression: a systematic review and meta-analysis. Neurosci Biobehav Rev 90:16\u201325. https:\/\/doi.org\/10.1016\/j.neubiorev.2018.03.023","journal-title":"Neurosci Biobehav Rev"},{"key":"8859_CR42","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1017\/neu.2016.31","volume":"29","author":"XC Liu","year":"2017","unstructured":"Liu XC, Erhardt S, Goiny M, Engberg G, Math\u00e9 AA (2017) Decreased levels of kynurenic acid in prefrontal cortex in a genetic animal model of depression. Acta Neuropsychiatr 29:54\u201358. https:\/\/doi.org\/10.1017\/neu.2016.31","journal-title":"Acta Neuropsychiatr"},{"key":"8859_CR43","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","volume":"70","author":"S Okuda","year":"1998","unstructured":"Okuda S, Nishiyama N, Saito H, Katsuki H (1998) 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J Neurochem 70:299\u2013307. https:\/\/doi.org\/10.1046\/j.1471-4159.1998.70010299.x","journal-title":"J Neurochem"},{"key":"8859_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0014-4835(84)90118-0","volume":"39","author":"J Dillon","year":"1984","unstructured":"Dillon J, Garcia Castineiras S, Santiago MA, Spector A (1984) The endopeptidase-resistant protein fraction from human cataractous lenses. Exp Eye Res 39:95\u2013106. https:\/\/doi.org\/10.1016\/0014-4835(84)90118-0","journal-title":"Exp Eye Res"},{"key":"8859_CR45","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1161\/circresaha.114.302113","volume":"114","author":"Q Wang","year":"2014","unstructured":"Wang Q, Zhang M, Ding Y, Wang Q, Zhang W, Song P, Zou MH (2014) Activation of NAD(P)H oxidase by tryptophan-derived 3-hydroxykynurenine accelerates endothelial apoptosis and dysfunction in vivo. Circ Res 114:480\u2013492. https:\/\/doi.org\/10.1161\/circresaha.114.302113","journal-title":"Circ Res"},{"key":"8859_CR46","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/0003-9861(92)90733-d","volume":"294","author":"T Ishii","year":"1992","unstructured":"Ishii T, Iwahashi H, Sugata R, Kido R (1992) Formation of hydroxanthommatin-derived radical in the oxidation of 3-hydroxykynurenine. Arch Biochem Biophys 294:616\u2013622. https:\/\/doi.org\/10.1016\/0003-9861(92)90733-d","journal-title":"Arch Biochem Biophys"},{"key":"8859_CR47","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1258\/0004563011900461","volume":"38","author":"T Morita","year":"2001","unstructured":"Morita T, Saito K, Takemura M et al (2001) 3-Hydroxyanthranilic acid, an L-tryptophan metabolite, induces apoptosis in monocyte-derived cells stimulated by interferon-gamma. Ann Clin Biochem 38:242\u2013251. https:\/\/doi.org\/10.1258\/0004563011900461","journal-title":"Ann Clin Biochem"},{"key":"8859_CR48","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1038\/sj.cdd.4401073","volume":"9","author":"F Fallarino","year":"2002","unstructured":"Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, Spreca A, Fioretti MC, Puccetti P (2002) T cell apoptosis by tryptophan catabolism. Cell Death Differ 9:1069\u20131077. https:\/\/doi.org\/10.1038\/sj.cdd.4401073","journal-title":"Cell Death Differ"},{"key":"8859_CR49","doi-asserted-by":"publisher","first-page":"18619","DOI":"10.1073\/pnas.0709261104","volume":"104","author":"T Hayashi","year":"2007","unstructured":"Hayashi T, Mo JH, Gong X et al (2007) 3-Hydroxyanthranilic acid inhibits PDK1 activation and suppresses experimental asthma by inducing T cell apoptosis. Proc Natl Acad Sci USA 104:18619\u201318624. https:\/\/doi.org\/10.1073\/pnas.0709261104","journal-title":"Proc Natl Acad Sci USA"},{"key":"8859_CR50","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1073\/pnas.87.7.2506","volume":"87","author":"S Christen","year":"1990","unstructured":"Christen S, Peterhans E, Stocker R (1990) Antioxidant activities of some tryptophan metabolites: possible implication for inflammatory diseases. Proc Natl Acad Sci USA 87:2506\u20132510. https:\/\/doi.org\/10.1073\/pnas.87.7.2506","journal-title":"Proc Natl Acad Sci USA"},{"key":"8859_CR51","doi-asserted-by":"publisher","first-page":"32714","DOI":"10.1074\/jbc.271.51.32714","volume":"271","author":"SR Thomas","year":"1996","unstructured":"Thomas SR, Witting PK, Stocker R (1996) 3-Hydroxyanthranilic acid is an efficient, cell-derived co-antioxidant for alpha-tocopherol, inhibiting human low density lipoprotein and plasma lipid peroxidation. J Biol Chem 271:32714\u201332721. https:\/\/doi.org\/10.1074\/jbc.271.51.32714","journal-title":"J Biol Chem"},{"key":"8859_CR52","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1016\/j.bbrc.2004.06.061","volume":"320","author":"GS Oh","year":"2004","unstructured":"Oh GS, Pae HO, Choi BM, Chae SC, Lee HS, Ryu DG, Chung HT (2004) 3-Hydroxyanthranilic acid, one of metabolites of tryptophan via indoleamine 2,3-dioxygenase pathway, suppresses inducible nitric oxide synthase expression by enhancing heme oxygenase-1 expression. Biochem Biophys Res Commun 320:1156\u20131162. https:\/\/doi.org\/10.1016\/j.bbrc.2004.06.061","journal-title":"Biochem Biophys Res Commun"},{"key":"8859_CR53","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s12640-009-9051-z","volume":"16","author":"N Braidy","year":"2009","unstructured":"Braidy N, Grant R, Adams S, Brew BJ, Guillemin GJ (2009) Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons. Neurotoxicol Res 16:77\u201386. https:\/\/doi.org\/10.1007\/s12640-009-9051-z","journal-title":"Neurotoxicol Res"},{"key":"8859_CR54","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1111\/j.1742-4658.2012.08485.x","volume":"279","author":"GJ Guillemin","year":"2012","unstructured":"Guillemin GJ (2012) Quinolinic acid, the inescapable neurotoxin. FEBS J 279:1356\u20131365. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08485.x","journal-title":"FEBS J"},{"key":"8859_CR55","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1097\/00001756-200108280-00020","volume":"12","author":"A Santamar\u00eda","year":"2001","unstructured":"Santamar\u00eda A, Jim\u00e9nez-Capdeville ME, Camacho A, Rodr\u00edguez-Mart\u00ednez E, Flores A, Galv\u00e1n-Arzate S (2001) In vivo hydroxyl radical formation after quinolinic acid infusion into rat corpus striatum. NeuroReport 12:2693\u20132696. https:\/\/doi.org\/10.1097\/00001756-200108280-00020","journal-title":"NeuroReport"},{"key":"8859_CR56","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1097\/00001756-200103260-00049","volume":"12","author":"A Santamar\u00eda","year":"2001","unstructured":"Santamar\u00eda A, Galv\u00e1n-Arzate S, Lis\u00fd V, Ali SF, Duhart HM, Osorio-Rico L, R\u00edos C, St\u2019astn\u00fd F (2001) Quinolinic acid induces oxidative stress in rat brain synaptosomes. NeuroReport 12:871\u2013874. https:\/\/doi.org\/10.1097\/00001756-200103260-00049","journal-title":"NeuroReport"},{"key":"8859_CR57","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.ijdevneu.2005.08.004","volume":"23","author":"G Leipnitz","year":"2005","unstructured":"Leipnitz G, Schumacher C, Scussiato K, Dalcin KB, Wannmacher CM, Wyse AT, Dutra-Filho CS, Wajner M, Latini A (2005) Quinolinic acid reduces the antioxidant defenses in cerebral cortex of young rats. Int J Dev Neurosci 23:695\u2013701. https:\/\/doi.org\/10.1016\/j.ijdevneu.2005.08.004","journal-title":"Int J Dev Neurosci"},{"key":"8859_CR58","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.cmet.2005.05.003","volume":"1","author":"KD Mansfield","year":"2005","unstructured":"Mansfield KD, Guzy RD, Pan Y, Young RM, Cash TP, Schumacker PT, Simon MC (2005) Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF-alpha activation. Cell Metab 1:393\u2013399. https:\/\/doi.org\/10.1016\/j.cmet.2005.05.003","journal-title":"Cell Metab"},{"key":"8859_CR59","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4137\/ijtr.s2318","volume":"2","author":"N Braidy","year":"2009","unstructured":"Braidy N, Grant R, Brew BJ, Adams S, Jayasena T, Guillemin GJ (2009) Effects of kynurenine pathway metabolites on intracellular NAD synthesis and cell death in human primary astrocytes and neurons. Int J Tryptophan Res 2:61\u201369. https:\/\/doi.org\/10.4137\/ijtr.s2318","journal-title":"Int J Tryptophan Res"},{"key":"8859_CR60","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/175855a0","volume":"175","author":"L Musajo","year":"1955","unstructured":"Musajo L, Benassi CA, Parpajola A (1955) Isolation of Kynurenine and 3-Hydroxykynurenine from Human Pathological Urine. Nature 175:855\u2013856. https:\/\/doi.org\/10.1038\/175855a0","journal-title":"Nature"},{"key":"8859_CR61","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0009-8981(59)90112-3","volume":"4","author":"SL Tompsett","year":"1959","unstructured":"Tompsett SL (1959) The determination in urine of some metabolites of tryptophan-kynurenine, anthranilic acid and 3-hydroxyanthranilic acid-and reference to the presence of o-aminophenol in urine. Clin Chim Acta 4:411\u2013419. https:\/\/doi.org\/10.1016\/0009-8981(59)90112-3","journal-title":"Clin Chim Acta"},{"key":"8859_CR62","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0003-2670(94)00493-6","volume":"302","author":"K-I Mawatari","year":"1995","unstructured":"Mawatari K-I, Oshida K, Iinuma F, Watanabe M (1995) Determination of quinolinic acid in human urine by liquid chromatography with fluorimetric detection. Anal Chim Acta 302:179\u2013183. https:\/\/doi.org\/10.1016\/0003-2670(94)00493-6","journal-title":"Anal Chim Acta"},{"key":"8859_CR63","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1053\/j.gastro.2017.08.028","volume":"153","author":"S Nikolaus","year":"2017","unstructured":"Nikolaus S, Schulte B, Al-Massad N et al (2017) Increased tryptophan metabolism is associated with activity of inflammatory bowel diseases. Gastroenterology 153:1504-1516.e1502. https:\/\/doi.org\/10.1053\/j.gastro.2017.08.028","journal-title":"Gastroenterology"},{"key":"8859_CR64","doi-asserted-by":"publisher","first-page":"698","DOI":"10.14336\/ad.2021.0824","volume":"13","author":"M Dehhaghi","year":"2022","unstructured":"Dehhaghi M, Panahi HKS, Kavyani B, Heng B, Tan V, Braidy N, Guillemin GJ (2022) The role of kynurenine pathway and NAD(+) metabolism in myalgic encephalomyelitis\/chronic fatigue syndrome. Aging Dis 13:698\u2013711. https:\/\/doi.org\/10.14336\/ad.2021.0824","journal-title":"Aging Dis"},{"key":"8859_CR65","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00406-014-0562-0","volume":"265","author":"M Busse","year":"2015","unstructured":"Busse M, Busse S, Myint AM, Gos T, Dobrowolny H, M\u00fcller UJ, Bogerts B, Bernstein HG, Steiner J (2015) Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses? Eur Arch Psychiatry Clin Neurosci 265:321\u2013329. https:\/\/doi.org\/10.1007\/s00406-014-0562-0","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"8859_CR66","doi-asserted-by":"publisher","first-page":"e865","DOI":"10.1038\/tp.2016.133","volume":"6","author":"L Brundin","year":"2016","unstructured":"Brundin L, Sellgren CM, Lim CK et al (2016) An enzyme in the kynurenine pathway that governs vulnerability to suicidal behavior by regulating excitotoxicity and neuroinflammation. Transl Psychiatry 6:e865\u2013e865. https:\/\/doi.org\/10.1038\/tp.2016.133","journal-title":"Transl Psychiatry"},{"key":"8859_CR67","doi-asserted-by":"publisher","first-page":"8128","DOI":"10.1016\/S0021-9258(17)37169-7","volume":"269","author":"G Melillo","year":"1994","unstructured":"Melillo G, Cox GW, Biragyn A, Sheffler LA, Varesio L (1994) Regulation of nitric-oxide synthase mRNA expression by interferon-gamma and picolinic acid. J Biol Chem 269:8128\u20138133","journal-title":"J Biol Chem"},{"key":"8859_CR68","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.4049\/jimmunol.164.6.3283","volume":"164","author":"MC Bosco","year":"2000","unstructured":"Bosco MC, Rapisarda A, Massazza S, Melillo G, Young H, Varesio L (2000) The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 alpha and -1 beta in macrophages. J Immunol 164:3283\u20133291. https:\/\/doi.org\/10.4049\/jimmunol.164.6.3283","journal-title":"J Immunol"},{"key":"8859_CR69","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/10715760000300451","volume":"32","author":"S Gaubert","year":"2000","unstructured":"Gaubert S, Bouchaut M, Brumas V, Berthon G (2000) Copper\u2013ligand interactions and the physiological free radical processes. Part 3. Influence of histidine, salicylic acid and anthranilic acid on copper-driven Fenton chemistry in vitro. Free Radic Res 32:451\u2013461. https:\/\/doi.org\/10.1080\/10715760000300451","journal-title":"Free Radic Res"},{"key":"8859_CR70","doi-asserted-by":"publisher","first-page":"646909","DOI":"10.1155\/2014\/646909","volume":"2014","author":"J Reyes Ocampo","year":"2014","unstructured":"Reyes Ocampo J, Lugo Huitr\u00f3n R, Gonz\u00e1lez-Esquivel D, Ugalde-Mu\u00f1iz P, Jim\u00e9nez-Anguiano A, Pineda B, Pedraza-Chaverri J, R\u00edos C, P\u00e9rez de la Cruz V (2014) Kynurenines with neuroactive and redox properties: relevance to aging and brain diseases. Oxid Med Cell Longev 2014:646909. https:\/\/doi.org\/10.1155\/2014\/646909","journal-title":"Oxid Med Cell Longev"},{"key":"8859_CR71","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-211-45295-0_45","author":"H N\u00e9meth","year":"2006","unstructured":"N\u00e9meth H, Toldi J, V\u00e9csei L (2006) Kynurenines, Parkinson\u2019s disease and other neurodegenerative disorders: preclinical and clinical studies. J Neural Transm Suppl. https:\/\/doi.org\/10.1007\/978-3-211-45295-0_45","journal-title":"J Neural Transm Suppl."},{"key":"8859_CR72","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","volume":"112","author":"R Schwarcz","year":"2017","unstructured":"Schwarcz R, Stone TW (2017) The kynurenine pathway and the brain: challenges, controversies and promises. Neuropharmacology 112:237\u2013247. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.08.003","journal-title":"Neuropharmacology"},{"key":"8859_CR73","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.neuropharm.2016.05.020","volume":"112","author":"S Erhardt","year":"2017","unstructured":"Erhardt S, Schwieler L, Imbeault S, Engberg G (2017) The kynurenine pathway in schizophrenia and bipolar disorder. Neuropharmacology 112:297\u2013306","journal-title":"Neuropharmacology"},{"key":"8859_CR74","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.1073\/pnas.1604453113","volume":"113","author":"C Breda","year":"2016","unstructured":"Breda C, Sathyasaikumar KV, Idrissi SS et al (2016) Tryptophan-2, 3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites. Proc Natl Acad Sci USA 113:5435\u20135440","journal-title":"Proc Natl Acad Sci USA"},{"key":"8859_CR75","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.pneurobio.2015.12.009","volume":"155","author":"CK Lim","year":"2017","unstructured":"Lim CK, Fernandez-Gomez FJ, Braidy N et al (2017) Involvement of the kynurenine pathway in the pathogenesis of Parkinson\u2019s disease. Prog Neurobiol 155:76\u201395","journal-title":"Prog Neurobiol"},{"key":"8859_CR76","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0306-4522(00)00504-2","volume":"102","author":"A Chiarugi","year":"2001","unstructured":"Chiarugi A, Cozzi A, Ballerini C, Massacesi L, Moroni F (2001) Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis. Neuroscience 102:687\u2013695","journal-title":"Neuroscience"},{"key":"8859_CR77","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1046\/j.1460-9568.1999.00806.x","volume":"11","author":"P Guidetti","year":"1999","unstructured":"Guidetti P, Schwarcz R (1999) 3-Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum. Eur J Neurosci 11:3857\u20133863","journal-title":"Eur J Neurosci"},{"key":"8859_CR78","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1046\/j.1471-4159.2001.00498.x","volume":"78","author":"GJ Guillemin","year":"2001","unstructured":"Guillemin GJ, Kerr SJ, Smythe GA, Smith DG, Kapoor V, Armati PJ, Croitoru J, Brew BJ (2001) Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J Neurochem 78:842\u2013853","journal-title":"J Neurochem"},{"key":"8859_CR79","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-1-4615-0135-0_19","volume":"527","author":"GJ Guillemin","year":"2003","unstructured":"Guillemin GJ, Williams KR, Smith DG, Smythe GA, Croitoru-Lamoury J, Brew BJ (2003) Quinolinic acid in the pathogenesis of Alzheimer\u2019s disease. Adv Exp Med Biol 527:167\u2013176. https:\/\/doi.org\/10.1007\/978-1-4615-0135-0_19","journal-title":"Adv Exp Med Biol"},{"key":"8859_CR80","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ensci.2020.100270","volume":"21","author":"D Venkatesan","year":"2020","unstructured":"Venkatesan D, Iyer M, Narayanasamy A, Siva K, Vellingiri B (2020) Kynurenine pathway in Parkinson\u2019s disease\u2014an update. eNeurologicalSci 21:270. https:\/\/doi.org\/10.1016\/j.ensci.2020.100270","journal-title":"eNeurologicalSci"},{"key":"8859_CR81","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1002\/mds.20459","volume":"20","author":"K Widnell","year":"2005","unstructured":"Widnell K (2005) Pathophysiology of motor fluctuations in Parkinson\u2019s disease. Mov Disord 20:S17\u2013S22","journal-title":"Mov Disord"},{"key":"8859_CR82","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/0014-2999(81)90587-2","volume":"72","author":"T Stone","year":"1981","unstructured":"Stone T, Perkins M (1981) Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur J Pharmacol 72:411\u2013412","journal-title":"Eur J Pharmacol"},{"key":"8859_CR83","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1002\/mds.25555","volume":"28","author":"PA LeWitt","year":"2013","unstructured":"LeWitt PA, Li J, Lu M, Beach TG, Adler CH, Guo L, Consortium APsD (2013) 3-hydroxykynurenine and other Parkinson\u2019s disease biomarkers discovered by metabolomic analysis. Mov Disord 28:1653\u20131660","journal-title":"Mov Disord"},{"key":"8859_CR84","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s007020200014","volume":"109","author":"B Widner","year":"2002","unstructured":"Widner B, Leblhuber F, Fuchs D (2002) Increased neopterin production and tryptophan degradation in advanced Parkinson\u2019s disease. J Neural Transm 109:181\u2013189","journal-title":"J Neural Transm"},{"key":"8859_CR85","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/S0306-4522(96)00655-0","volume":"78","author":"A Miranda","year":"1997","unstructured":"Miranda A, Boegman R, Beninger R, Jhamandas K (1997) Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid. Neuroscience 78:967\u2013975","journal-title":"Neuroscience"},{"key":"8859_CR86","doi-asserted-by":"publisher","first-page":"e0115439","DOI":"10.1371\/journal.pone.0115439","volume":"10","author":"A Kubesova","year":"2015","unstructured":"Kubesova A, Tejkalova H, Syslova K, Kacer P, Vondrousova J, Tyls F, Fujakova M, Palenicek T, Horacek J (2015) Biochemical, histopathological and morphological profiling of a rat model of early immune stimulation: relation to psychopathology. PLoS ONE 10:e0115439","journal-title":"PLoS ONE"},{"key":"8859_CR87","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0024-3205(90)90376-3","volume":"47","author":"W Graham","year":"1990","unstructured":"Graham W, Robertson R, Sambrook M, Crossman A (1990) Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism. Life Sci 47:91\u201397","journal-title":"Life Sci"},{"key":"8859_CR88","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/mds.870060208","volume":"6","author":"JM Brotchie","year":"1991","unstructured":"Brotchie JM, Mitchell IJ, Sambrook MA, Crossman AR (1991) Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate. Mov Disord 6:133\u2013138","journal-title":"Mov Disord"},{"key":"8859_CR89","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00401-006-0086-4","volume":"112","author":"E Knyih\u00e1r-Csillik","year":"2006","unstructured":"Knyih\u00e1r-Csillik E, Chadaide Z, Mih\u00e1ly A, Krisztin-P\u00e9va B, Feny\u0151 R, V\u00e9csei L (2006) Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra. Acta Neuropathol 112:127\u2013137","journal-title":"Acta Neuropathol"},{"key":"8859_CR90","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ejcb.2008.03.003","volume":"87","author":"K-S Lee","year":"2008","unstructured":"Lee K-S, Lee HJ, Noh YH et al (2008) Kynurenic acid attenuates MPP+-induced dopaminergic neuronal cell death via a Bax-mediated mitochondrial pathway. Eur J Cell Biol 87:389\u2013397","journal-title":"Eur J Cell Biol"},{"key":"8859_CR91","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00702-006-0562-y","volume":"114","author":"HQ Wu","year":"2007","unstructured":"Wu HQ, Rassoulpour A, Schwarcz R (2007) Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain? J Neural Transm (Vienna) 114:33\u201341. https:\/\/doi.org\/10.1007\/s00702-006-0562-y","journal-title":"J Neural Transm (Vienna)"},{"key":"8859_CR92","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00702-006-0562-y","volume":"114","author":"H-Q Wu","year":"2007","unstructured":"Wu H-Q, Rassoulpour A, Schwarcz R (2007) Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain? J Neural Transm 114:33\u201341","journal-title":"J Neural Transm"},{"key":"8859_CR93","doi-asserted-by":"crossref","unstructured":"Oxenkrug G, van der Hart M, Roeser J, Summergrad P (2017) Peripheral tryptophan-kynurenine metabolism associated with metabolic syndrome is different in Parkinson\u2019s and Alzheimer\u2019s diseases. Endocrinol Diabetes Metab J 1","DOI":"10.31038\/EDMJ.2017141"},{"key":"8859_CR94","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/jnc.14104","volume":"142","author":"JF Havelund","year":"2017","unstructured":"Havelund JF, Andersen AD, Binzer M, Blaabjerg M, Heegaard NH, Stenager E, Faergeman NJ, Gramsbergen JB (2017) Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia. J Neurochem 142:756\u2013766","journal-title":"J Neurochem"},{"key":"8859_CR95","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1212\/WNL.42.9.1702","volume":"42","author":"T Ogawa","year":"1992","unstructured":"Ogawa T, Matson W, Beal M, Myers R, Bird E, Milbury P, Saso S (1992) Kynurenine pathway abnormalities in Parkinson\u2019s disease. Neurology 42:1702\u20131702","journal-title":"Neurology"},{"key":"8859_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep13888","volume":"5","author":"H Luan","year":"2015","unstructured":"Luan H, Liu L-F, Tang Z, Zhang M, Chua K-K, Song J-X, Mok VC, Li M, Cai Z (2015) Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson\u2019s disease. Sci Rep 5:1\u201311","journal-title":"Sci Rep"},{"key":"8859_CR97","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/jnc.14843","volume":"151","author":"FJ Sorgdrager","year":"2019","unstructured":"Sorgdrager FJ, Vermeiren Y, Van Faassen M, Van Der Ley C, Nollen EA, Kema IP, De Deyn PP (2019) Age-and disease-specific changes of the kynurenine pathway in Parkinson\u2019s and Alzheimer\u2019s disease. J Neurochem 151:656\u2013668","journal-title":"J Neurochem"},{"key":"8859_CR98","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2012.08.005","volume":"323","author":"L Tan","year":"2012","unstructured":"Tan L, Yu JT, Tan L (2012) The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations. J Neurol Sci 323:1\u20138. https:\/\/doi.org\/10.1016\/j.jns.2012.08.005","journal-title":"J Neurol Sci"},{"key":"8859_CR99","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.pneurobio.2015.12.009","volume":"155","author":"CK Lim","year":"2017","unstructured":"Lim CK, Fern\u00e1ndez-Gomez FJ, Braidy N et al (2017) Involvement of the kynurenine pathway in the pathogenesis of Parkinson\u2019s disease. Prog Neurobiol 155:76\u201395. https:\/\/doi.org\/10.1016\/j.pneurobio.2015.12.009","journal-title":"Prog Neurobiol"},{"key":"8859_CR100","first-page":"231","volume":"48","author":"A Ravikumar","year":"2000","unstructured":"Ravikumar A, Deepadevi K, Arun P, Manojkumar V, Kurup P (2000) Tryptophan and tyrosine catabolic pattern in neuropsychiatric disorders. Neurol India 48:231","journal-title":"Neurol India"},{"key":"8859_CR101","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/978-3-211-45295-0_45","volume":"70","author":"H Nemeth","year":"2006","unstructured":"Nemeth H, Toldi J, V\u00e9csei L (2006) Kynurenines, Parkinson\u2019s disease and other neurodegenerative disorders: preclinical and clinical studies. Parkinson\u2019s Dis Relat Disord 70:285\u2013304","journal-title":"Parkinson\u2019s Dis Relat Disord"},{"key":"8859_CR102","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2478\/v10039-010-0023-6","volume":"55","author":"E Gulaj","year":"2010","unstructured":"Gulaj E, Pawlak K, Bien B, Pawlak D (2010) Kynurenine and its metabolites in Alzheimer\u2019s disease patients. Adv Med Sci 55:204\u2013211. https:\/\/doi.org\/10.2478\/v10039-010-0023-6","journal-title":"Adv Med Sci"},{"key":"8859_CR103","first-page":"441","volume":"56","author":"J Greilberger","year":"2010","unstructured":"Greilberger J, Fuchs D, Leblhuber F, Greilberger M, Wintersteiger R, Tafeit E (2010) Carbonyl proteins as a clinical marker in Alzheimer\u2019s disease and its relation to tryptophan degradation and immune activation. Clin Lab 56:441\u2013448","journal-title":"Clin Lab"},{"key":"8859_CR104","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00406-012-0384-x","volume":"263","author":"MJ Schwarz","year":"2013","unstructured":"Schwarz MJ, Guillemin GJ, Teipel SJ, Buerger K, Hampel H (2013) Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer\u2019s disease patients from controls. Eur Arch Psychiatry Clin Neurosci 263:345\u2013352. https:\/\/doi.org\/10.1007\/s00406-012-0384-x","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"8859_CR105","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3233\/jad-170485","volume":"60","author":"LM Giil","year":"2017","unstructured":"Giil LM, Midttun \u00d8, Refsum H, Ulvik A, Advani R, Smith AD, Ueland PM (2017) Kynurenine pathway metabolites in Alzheimer\u2019s disease. J Alzheimers Dis 60:495\u2013504. https:\/\/doi.org\/10.3233\/jad-170485","journal-title":"J Alzheimers Dis"},{"key":"8859_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174310","volume":"908","author":"P Babaei","year":"2021","unstructured":"Babaei P (2021) NMDA and AMPA receptors dysregulation in Alzheimer\u2019s disease. Eur J Pharmacol 908:174310. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174310","journal-title":"Eur J Pharmacol"},{"key":"8859_CR107","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/cns.13768","volume":"28","author":"A Ostapiuk","year":"2022","unstructured":"Ostapiuk A, Urbanska EM (2022) Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword? CNS Neurosci Ther 28:19\u201335. https:\/\/doi.org\/10.1111\/cns.13768","journal-title":"CNS Neurosci Ther"},{"key":"8859_CR108","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s007020050149","volume":"106","author":"H Baran","year":"1999","unstructured":"Baran H, Jellinger K, Deecke L (1999) Kynurenine metabolism in Alzheimer\u2019s disease. J Neural Transm (Vienna) 106:165\u2013181. https:\/\/doi.org\/10.1007\/s007020050149","journal-title":"J Neural Transm (Vienna)"},{"key":"8859_CR109","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ics.2007.07.012","volume":"1304","author":"GJ Guillemin","year":"2007","unstructured":"Guillemin GJ, Brew BJ, Noonan CE, Knight TG, Smythe GA, Cullen KM (2007) Mass spectrometric detection of quinolinic acid in microdissected Alzheimer\u2019s disease plaques. Int Congress Ser 1304:404\u2013408. https:\/\/doi.org\/10.1016\/j.ics.2007.07.012","journal-title":"Int Congress Ser"},{"key":"8859_CR110","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/s0301-0082(00)00032-0","volume":"64","author":"TW Stone","year":"2001","unstructured":"Stone TW (2001) Kynurenines in the CNS: from endogenous obscurity to therapeutic importance. Prog Neurobiol 64:185\u2013218. https:\/\/doi.org\/10.1016\/s0301-0082(00)00032-0","journal-title":"Prog Neurobiol"},{"key":"8859_CR111","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/s0197-0186(01)00133-4","volume":"40","author":"RG Tavares","year":"2002","unstructured":"Tavares RG, Tasca CI, Santos CE, Alves LB, Porci\u00fancula LO, Emanuelli T, Souza DO (2002) Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes. Neurochem Int 40:621\u2013627. https:\/\/doi.org\/10.1016\/s0197-0186(01)00133-4","journal-title":"Neurochem Int"},{"key":"8859_CR112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123289","volume":"10","author":"S Matsunaga","year":"2015","unstructured":"Matsunaga S, Kishi T, Iwata N (2015) Memantine monotherapy for Alzheimer\u2019s disease: a systematic review and meta-analysis. PLoS ONE 10:e0123289. https:\/\/doi.org\/10.1371\/journal.pone.0123289","journal-title":"PLoS ONE"},{"key":"8859_CR113","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/mus.10191","volume":"26","author":"PL McGeer","year":"2002","unstructured":"McGeer PL, McGeer EG (2002) Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26:459\u2013470. https:\/\/doi.org\/10.1002\/mus.10191","journal-title":"Muscle Nerve"},{"key":"8859_CR114","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s12640-009-9129-7","volume":"18","author":"Y Chen","year":"2010","unstructured":"Chen Y, Stankovic R, Cullen KM, Meininger V, Garner B, Coggan S, Grant R, Brew BJ, Guillemin GJ (2010) The kynurenine pathway and inflammation in amyotrophic lateral sclerosis. Neurotoxicol Res 18:132\u2013142. https:\/\/doi.org\/10.1007\/s12640-009-9129-7","journal-title":"Neurotoxicol Res"},{"key":"8859_CR115","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1034\/j.1600-0404.2003.00076.x","volume":"107","author":"J I\u0142zecka","year":"2003","unstructured":"I\u0142zecka J, Kocki T, Stelmasiak Z, Turski WA (2003) Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis. Acta Neurol Scand 107:412\u2013418. https:\/\/doi.org\/10.1034\/j.1600-0404.2003.00076.x","journal-title":"Acta Neurol Scand"},{"key":"8859_CR116","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3389\/fnins.2019.01013","volume":"13","author":"VX Tan","year":"2019","unstructured":"Tan VX, Guillemin GJ (2019) Kynurenine pathway metabolites as biomarkers for amyotrophic lateral sclerosis. Front Neurosci 13:1013. https:\/\/doi.org\/10.3389\/fnins.2019.01013","journal-title":"Front Neurosci"},{"key":"8859_CR117","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s12031-018-1173-4","volume":"66","author":"LY Ao","year":"2018","unstructured":"Ao LY, Yan YY, Zhou L, Li CY, Li WT, Fang WR, Li YM (2018) Immune cells after ischemic stroke onset: roles, migration, and target intervention. J Mol Neurosci 66:342\u2013355. https:\/\/doi.org\/10.1007\/s12031-018-1173-4","journal-title":"J Mol Neurosci"},{"key":"8859_CR118","doi-asserted-by":"publisher","first-page":"117864691769193","DOI":"10.1177\/1178646917691938","volume":"10","author":"AA Badawy","year":"2017","unstructured":"Badawy AA (2017) Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects. Int J Tryptophan Res 10:1178646917691938. https:\/\/doi.org\/10.1177\/1178646917691938","journal-title":"Int J Tryptophan Res"},{"key":"8859_CR119","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1111\/j.1460-9568.2007.05838.x","volume":"26","author":"LG Darlington","year":"2007","unstructured":"Darlington LG, Mackay GM, Forrest CM, Stoy N, George C, Stone TW (2007) Altered kynurenine metabolism correlates with infarct volume in stroke. Eur J Neurosci 26:2211\u20132221. https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05838.x","journal-title":"Eur J Neurosci"},{"key":"8859_CR120","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3389\/fneur.2019.00778","volume":"10","author":"GD Colpo","year":"2019","unstructured":"Colpo GD, Venna VR, McCullough LD, Teixeira AL (2019) Systematic review on the involvement of the kynurenine pathway in stroke: pre-clinical and clinical evidence. Front Neurol 10:778. https:\/\/doi.org\/10.3389\/fneur.2019.00778","journal-title":"Front Neurol"},{"key":"8859_CR121","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1089\/ars.2007.1672","volume":"10","author":"W Ying","year":"2008","unstructured":"Ying W (2008) NAD+\/NADH and NADP+\/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal 10:179\u2013206. https:\/\/doi.org\/10.1089\/ars.2007.1672","journal-title":"Antioxid Redox Signal"},{"key":"8859_CR122","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ejphar.2007.02.029","volume":"564","author":"G Gigler","year":"2007","unstructured":"Gigler G, Sz\u00e9n\u00e1si G, Sim\u00f3 A, L\u00e9vay G, H\u00e1rsing LG Jr, Sas K, V\u00e9csei L, Toldi J (2007) Neuroprotective effect of L-kynurenine sulfate administered before focal cerebral ischemia in mice and global cerebral ischemia in gerbils. Eur J Pharmacol 564:116\u2013122. https:\/\/doi.org\/10.1016\/j.ejphar.2007.02.029","journal-title":"Eur J Pharmacol"},{"key":"8859_CR123","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2217\/14796708.3.2.169","volume":"3","author":"H Robotka","year":"2008","unstructured":"Robotka H, Toldi J, V\u00e9csei L (2008) L-kynurenine: metabolism and mechanism of neuroprotection. Future Neurol 3:169\u2013188. https:\/\/doi.org\/10.2217\/14796708.3.2.169","journal-title":"Future Neurol"},{"key":"8859_CR124","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ejphar.2011.05.069","volume":"667","author":"L Gell\u00e9rt","year":"2011","unstructured":"Gell\u00e9rt L, Fuzik J, G\u00f6bl\u00f6s A et al (2011) Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia. Eur J Pharmacol 667:182\u2013187. https:\/\/doi.org\/10.1016\/j.ejphar.2011.05.069","journal-title":"Eur J Pharmacol"},{"key":"8859_CR125","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1471-4159.1993.tb05836.x","volume":"60","author":"K Saito","year":"1993","unstructured":"Saito K, Nowak TS Jr, Markey SP, Heyes MP (1993) Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia. J Neurochem 60:180\u2013192","journal-title":"J Neurochem"},{"key":"8859_CR126","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1038\/mp.2013.11","volume":"19","author":"C Lavebratt","year":"2014","unstructured":"Lavebratt C, Olsson S, Backlund L et al (2014) The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression. Mol Psychiatry 19:334\u2013341. https:\/\/doi.org\/10.1038\/mp.2013.11","journal-title":"Mol Psychiatry"},{"key":"8859_CR127","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s11064-010-0187-2","volume":"35","author":"R Brouns","year":"2010","unstructured":"Brouns R, Verkerk R, Aerts T, De Surgeloose D, Wauters A, Scharp\u00e9 S, De Deyn PP (2010) The role of tryptophan catabolism along the kynurenine pathway in acute ischemic stroke. Neurochem Res 35:1315\u20131322","journal-title":"Neurochem Res"},{"key":"8859_CR128","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.0077","author":"GD Colpo","year":"2019","unstructured":"Colpo GD, Venna VR, McCullough LD, Teixeira AL (2019) Systematic review on the involvement of the kynurenine pathway in stroke: pre-clinical and clinical evidence. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2019.0077","journal-title":"Front Neurol"},{"key":"8859_CR129","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1528-1157.1994.tb02428.x","volume":"35","author":"MP Heyes","year":"1994","unstructured":"Heyes MP, Saito K, Devinsky O, Nadi NS (1994) Kynurenine pathway metabolites in cerebrospinal fluid and serum in complex partial seizures. Epilepsia 35:251\u2013257. https:\/\/doi.org\/10.1111\/j.1528-1157.1994.tb02428.x","journal-title":"Epilepsia"},{"key":"8859_CR130","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/0028-3908(82)90125-3","volume":"21","author":"IP Lapin","year":"1982","unstructured":"Lapin IP (1982) Convulsant action of intracerebroventricularly administered l-kynurenine sulphate, quinolinic acid and other derivatives of succinic acid, and effects of amino acids: structure-activity relationships. Neuropharmacology 21:1227\u20131233. https:\/\/doi.org\/10.1016\/0028-3908(82)90125-3","journal-title":"Neuropharmacology"},{"key":"8859_CR131","first-page":"309","volume":"45","author":"TW Stone","year":"1993","unstructured":"Stone TW (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 45:309\u2013379","journal-title":"Pharmacol Rev"},{"key":"8859_CR132","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.seizure.2019.05.006","volume":"69","author":"I \u017barnowska","year":"2019","unstructured":"\u017barnowska I, Wr\u00f3bel-Dudzi\u0144ska D, Tulidowicz-Bielak M, Kocki T, Mitosek-Szewczyk K, Gasior M, Turski WA (2019) Changes in tryptophan and kynurenine pathway metabolites in the blood of children treated with ketogenic diet for refractory epilepsy. Seizure Eur J Epilepsy 69:265\u2013272. https:\/\/doi.org\/10.1016\/j.seizure.2019.05.006","journal-title":"Seizure Eur J Epilepsy"},{"key":"8859_CR133","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.pbb.2015.03.002","volume":"132","author":"G Veres","year":"2015","unstructured":"Veres G, Moln\u00e1r M, Z\u00e1dori D et al (2015) Central nervous system-specific alterations in the tryptophan metabolism in the 3-nitropropionic acid model of Huntington\u2019s disease. Pharmacol Biochem Behav 132:115\u2013124","journal-title":"Pharmacol Biochem Behav"},{"key":"8859_CR134","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3389\/fncel.2021.638854","volume":"15","author":"N Deng","year":"2021","unstructured":"Deng N, Hu J, Hong Y, Ding Y, Xiong Y, Wu Z, Xie W (2021) Indoleamine-2, 3-dioxygenase 1 deficiency suppresses seizures in epilepsy. Front Cell Neurosci 15:28","journal-title":"Front Cell Neurosci"},{"key":"8859_CR135","first-page":"293","volume":"236","author":"AH Ganong","year":"1986","unstructured":"Ganong AH, Cotman CW (1986) Kynurenic acid and quinolinic acid act at N-methyl-D-aspartate receptors in the rat hippocampus. J Pharmacol Exp Ther 236:293\u2013299","journal-title":"J Pharmacol Exp Ther"},{"key":"8859_CR136","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuropharm.2016.01.011","volume":"112","author":"H Fujigaki","year":"2017","unstructured":"Fujigaki H, Yamamoto Y, Saito K (2017) L-Tryptophan-kynurenine pathway enzymes are therapeutic target for neuropsychiatric diseases: focus on cell type differences. Neuropharmacology 112:264\u2013274","journal-title":"Neuropharmacology"},{"key":"8859_CR137","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12071397","author":"AD de Melo","year":"2023","unstructured":"de Melo AD, Freire VAF, Diogo \u00cdL, Santos HL, Barbosa LA, de Carvalho LED (2023) Antioxidant Therapy Reduces Oxidative Stress, Restores Na,K-ATPase function and induces neuroprotection in rodent models of seizure and epilepsy: a systematic review and meta-analysis. Antioxidants (Basel). https:\/\/doi.org\/10.3390\/antiox12071397","journal-title":"Antioxidants (Basel)"},{"key":"8859_CR138","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.freeradbiomed.2020.07.038","volume":"160","author":"C Mo","year":"2020","unstructured":"Mo C, Xie S, Zhong W et al (2020) Mutual antagonism between indoleamine 2, 3-dioxygenase 1 and nuclear factor E2-related factor 2 regulates the maturation status of DCs in liver fibrosis. Free Radic Biol Med 160:178\u2013190","journal-title":"Free Radic Biol Med"},{"key":"8859_CR139","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.freeradbiomed.2020.01.009","volume":"152","author":"T Zeng","year":"2020","unstructured":"Zeng T, Deng G, Zhong W et al (2020) Indoleamine 2, 3-dioxygenase 1enhanceshepatocytes ferroptosis in acute immune hepatitis associated with excess nitrative stress. Free Radic Biol Med 152:668\u2013679","journal-title":"Free Radic Biol Med"},{"key":"8859_CR140","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612912","author":"E L\u00f3pez-Muguruza","year":"2023","unstructured":"L\u00f3pez-Muguruza E, Matute C (2023) Alterations of oligodendrocyte and myelin energy metabolism in multiple sclerosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241612912","journal-title":"Int J Mol Sci"},{"key":"8859_CR141","volume-title":"Harrison's principles of internal medicine","author":"D Kasper","year":"2015","unstructured":"Kasper D, Fauci A, Hauser S, Longo D, Jameson J, Loscalzo J (2015) Harrison\u2019s principles of internal medicine, 19th edn. Mcgraw-Hill, New York","edition":"19"},{"key":"8859_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061564","author":"T Biernacki","year":"2020","unstructured":"Biernacki T, Sandi D, Bencsik K, V\u00e9csei L (2020) Kynurenines in the pathogenesis of multiple sclerosis: therapeutic perspectives. Cells. https:\/\/doi.org\/10.3390\/cells9061564","journal-title":"Cells"},{"key":"8859_CR143","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s12974-020-01844-y","volume":"17","author":"G Sundaram","year":"2020","unstructured":"Sundaram G, Lim CK, Brew BJ, Guillemin GJ (2020) Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression. J Neuroinflamm 17:176. https:\/\/doi.org\/10.1186\/s12974-020-01844-y","journal-title":"J Neuroinflamm"},{"key":"8859_CR144","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1096\/fj.04-3228fje","volume":"19","author":"E Kwidzinski","year":"2005","unstructured":"Kwidzinski E, Bunse J, Aktas O, Richter D, Mutlu L, Zipp F, Nitsch R, Bechmann I (2005) Indolamine 2, 3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation. FASEB J 19:1347\u20131349","journal-title":"FASEB J"},{"key":"8859_CR145","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S0165-5728(02)00176-5","volume":"129","author":"K Sakurai","year":"2002","unstructured":"Sakurai K, Zou J-P, Tschetter JR, Ward JM, Shearer GM (2002) Effect of indoleamine 2, 3-dioxygenase on induction of experimental autoimmune encephalomyelitis. J Neuroimmunol 129:186\u2013196","journal-title":"J Neuroimmunol"},{"key":"8859_CR146","doi-asserted-by":"publisher","first-page":"5953","DOI":"10.4049\/jimmunol.1001628","volume":"185","author":"Y Yan","year":"2010","unstructured":"Yan Y, Zhang G-X, Gran B, Fallarino F, Yu S, Li H, Cullimore ML, Rostami A, Xu H (2010) IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis. J Immunol 185:5953\u20135961","journal-title":"J Immunol"},{"key":"8859_CR147","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.steroids.2004.05.019","volume":"69","author":"B-G Xiao","year":"2004","unstructured":"Xiao B-G, Liu X, Link H (2004) Antigen-specific T cell functions are suppressed over the estrogen-dendritic cell-indoleamine 2, 3-dioxygenase axis. Steroids 69:653\u2013659","journal-title":"Steroids"},{"key":"8859_CR148","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1117634","volume":"310","author":"M Platten","year":"2005","unstructured":"Platten M, Ho PP, Youssef S et al (2005) Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 310:850\u2013855","journal-title":"Science"},{"key":"8859_CR149","doi-asserted-by":"publisher","first-page":"18270","DOI":"10.3390\/ijms160818270","volume":"16","author":"C Rajda","year":"2015","unstructured":"Rajda C, Majl\u00e1th Z, Pukoli D, V\u00e9csei L (2015) Kynurenines and multiple sclerosis: the dialogue between the immune system and the central nervous system. Int J Mol Sci 16:18270\u201318282","journal-title":"Int J Mol Sci"},{"key":"8859_CR150","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0300-483X(99)00116-X","volume":"139","author":"E Rodr\u00edguez","year":"1999","unstructured":"Rodr\u00edguez E, M\u00e9ndez-Armenta M, Villeda-Hern\u00e1ndez J, Galv\u00e1n-Arzate S, Barroso-Moguel R, Rodr\u00edguez F, R\u00edos C, Santamar\u00eda A (1999) Dapsone prevents morphological lesions and lipid peroxidation induced by quinolinic acid in rat corpus striatum. Toxicology 139:111\u2013118","journal-title":"Toxicology"},{"key":"8859_CR151","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000056082","volume":"62","author":"H Baran","year":"2001","unstructured":"Baran H, Staniek K, Kepplinger B, Gille L, Stolze K, Nohl H (2001) Kynurenic acid influences the respiratory parameters of rat heart mitochondria. Pharmacology 62:119\u2013123","journal-title":"Pharmacology"},{"key":"8859_CR152","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1046\/j.1471-4159.1995.64031192.x","volume":"64","author":"EM Flanagan","year":"1995","unstructured":"Flanagan EM, Erickson JB, Viveros OH, Chang SY, Reinhard JF Jr (1995) Neurotoxin quinolinic acid is selectively elevated in spinal cords of rats with experimental allergic encephalomyelitis. J Neurochem 64:1192\u20131196","journal-title":"J Neurochem"},{"key":"8859_CR153","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nrd3793","volume":"12","author":"L V\u00e9csei","year":"2013","unstructured":"V\u00e9csei L, Szal\u00e1rdy L, F\u00fcl\u00f6p F, Toldi J (2013) Kynurenines in the CNS: recent advances and new questions. Nat Rev Drug Discov 12:64\u201382","journal-title":"Nat Rev Drug Discov"},{"key":"8859_CR154","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1089\/jir.1997.17.589","volume":"17","author":"LA Pemberton","year":"1997","unstructured":"Pemberton LA, Kerr SJ, Smythe G, Brew BJ (1997) Quinolinic acid production by macrophages stimulated with IFN-\u03b3, TNF-\u03b1, and IFN-\u03b1. J Interferon Cytokine Res 17:589\u2013595","journal-title":"J Interferon Cytokine Res"},{"key":"8859_CR155","unstructured":"Bains N, Abdijadid S (2023) Major depressive disorder. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island"},{"key":"8859_CR156","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bbi.2014.07.012","volume":"43","author":"C Bay-Richter","year":"2015","unstructured":"Bay-Richter C, Linderholm KR, Lim CK, Samuelsson M, Tr\u00e4skman-Bendz L, Guillemin GJ, Erhardt S, Brundin L (2015) A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality. Brain Behav Immun 43:110\u2013117. https:\/\/doi.org\/10.1016\/j.bbi.2014.07.012","journal-title":"Brain Behav Immun"},{"key":"8859_CR157","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/npp.2014.194","volume":"40","author":"J Savitz","year":"2015","unstructured":"Savitz J, Drevets WC, Smith CM, Victor TA, Wurfel BE, Bellgowan PS, Bodurka J, Teague TK, Dantzer R (2015) Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdalar volumes in subjects with major depressive disorder. Neuropsychopharmacology 40:463\u2013471. https:\/\/doi.org\/10.1038\/npp.2014.194","journal-title":"Neuropsychopharmacology"},{"key":"8859_CR158","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/7854_2016_12","volume":"31","author":"J Savitz","year":"2017","unstructured":"Savitz J (2017) Role of kynurenine metabolism pathway activation in major depressive disorders. Curr Top Behav Neurosci 31:249\u2013267. https:\/\/doi.org\/10.1007\/7854_2016_12","journal-title":"Curr Top Behav Neurosci"},{"key":"8859_CR159","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1742-2094-10-87","volume":"10","author":"MA Lawson","year":"2013","unstructured":"Lawson MA, Parrott JM, McCusker RH, Dantzer R, Kelley KW, O\u2019Connor JC (2013) Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors. J Neuroinflamm 10:87. https:\/\/doi.org\/10.1186\/1742-2094-10-87","journal-title":"J Neuroinflamm"},{"key":"8859_CR160","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/sj.mp.4000995","volume":"7","author":"L Capuron","year":"2002","unstructured":"Capuron L, Ravaud A, Neveu PJ, Miller AH, Maes M, Dantzer R (2002) Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol Psychiatry 7:468\u2013473. https:\/\/doi.org\/10.1038\/sj.mp.4000995","journal-title":"Mol Psychiatry"},{"key":"8859_CR161","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.psychres.2015.03.031","volume":"227","author":"KA Bradley","year":"2015","unstructured":"Bradley KA, Case JA, Khan O, Ricart T, Hanna A, Alonso CM, Gabbay V (2015) The role of the kynurenine pathway in suicidality in adolescent major depressive disorder. Psychiatry Res 227:206\u2013212. https:\/\/doi.org\/10.1016\/j.psychres.2015.03.031","journal-title":"Psychiatry Res"},{"key":"8859_CR162","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.psyneuen.2014.11.015","volume":"52","author":"J Savitz","year":"2015","unstructured":"Savitz J, Dantzer R, Wurfel BE, Victor TA, Ford BN, Bodurka J, Bellgowan PS, Teague TK, Drevets WC (2015) Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder. Psychoneuroendocrinology 52:200\u2013211. https:\/\/doi.org\/10.1016\/j.psyneuen.2014.11.015","journal-title":"Psychoneuroendocrinology"},{"key":"8859_CR163","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbi.2015.02.007","volume":"46","author":"J Savitz","year":"2015","unstructured":"Savitz J, Drevets WC, Wurfel BE, Ford BN, Bellgowan PS, Victor TA, Bodurka J, Teague TK, Dantzer R (2015) Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder. Brain Behav Immun 46:55\u201359. https:\/\/doi.org\/10.1016\/j.bbi.2015.02.007","journal-title":"Brain Behav Immun"},{"key":"8859_CR164","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/s0306-9877(03)00207-x","volume":"61","author":"AM Myint","year":"2003","unstructured":"Myint AM, Kim YK (2003) Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypotheses 61:519\u2013525. https:\/\/doi.org\/10.1016\/s0306-9877(03)00207-x","journal-title":"Med Hypotheses"},{"key":"8859_CR165","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jad.2006.07.013","volume":"98","author":"AM Myint","year":"2007","unstructured":"Myint AM, Kim YK, Verkerk R, Scharp\u00e9 S, Steinbusch H, Leonard B (2007) Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord 98:143\u2013151. https:\/\/doi.org\/10.1016\/j.jad.2006.07.013","journal-title":"J Affect Disord"},{"key":"8859_CR166","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2165\/00023210-200923020-00001","volume":"23","author":"S Erhardt","year":"2009","unstructured":"Erhardt S, Olsson SK, Engberg G (2009) Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders. CNS Drugs 23:91\u2013101. https:\/\/doi.org\/10.2165\/00023210-200923020-00001","journal-title":"CNS Drugs"},{"key":"8859_CR167","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrn3257","volume":"13","author":"R Schwarcz","year":"2012","unstructured":"Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13:465\u2013477. https:\/\/doi.org\/10.1038\/nrn3257","journal-title":"Nat Rev Neurosci"},{"key":"8859_CR168","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/s0304-3940(01)02242-x","volume":"313","author":"S Erhardt","year":"2001","unstructured":"Erhardt S, Blennow K, Nordin C, Skogh E, Lindstr\u00f6m LH, Engberg G (2001) Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci Lett 313:96\u201398. https:\/\/doi.org\/10.1016\/s0304-3940(01)02242-x","journal-title":"Neurosci Lett"},{"key":"8859_CR169","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.brainres.2005.12.056","volume":"1073\u20131074","author":"CL Miller","year":"2006","unstructured":"Miller CL, Llenos IC, Dulay JR, Weis S (2006) Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder. Brain Res 1073\u20131074:25\u201337. https:\/\/doi.org\/10.1016\/j.brainres.2005.12.056","journal-title":"Brain Res"},{"key":"8859_CR170","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.biopsych.2004.06.006","volume":"56","author":"S Erhardt","year":"2004","unstructured":"Erhardt S, Schwieler L, Emanuelsson C, Geyer M (2004) Endogenous kynurenic acid disrupts prepulse inhibition. Biol Psychiatry 56:255\u2013260. https:\/\/doi.org\/10.1016\/j.biopsych.2004.06.006","journal-title":"Biol Psychiatry"},{"key":"8859_CR171","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fnins.2014.00012","volume":"8","author":"BM Campbell","year":"2014","unstructured":"Campbell BM, Charych E, Lee AW, M\u00f6ller T (2014) Kynurenines in CNS disease: regulation by inflammatory cytokines. Front Neurosci 8:12. https:\/\/doi.org\/10.3389\/fnins.2014.00012","journal-title":"Front Neurosci"},{"key":"8859_CR172","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4137\/ijtr.s16800","volume":"7","author":"ME Kegel","year":"2014","unstructured":"Kegel ME, Bhat M, Skogh E et al (2014) Imbalanced kynurenine pathway in schizophrenia. Int J Tryptophan Res 7:15\u201322. https:\/\/doi.org\/10.4137\/ijtr.s16800","journal-title":"Int J Tryptophan Res"},{"key":"8859_CR173","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/npp.2011.277","volume":"37","author":"PA Zunszain","year":"2012","unstructured":"Zunszain PA, Anacker C, Cattaneo A, Choudhury S, Musaelyan K, Myint AM, Thuret S, Price J, Pariante CM (2012) Interleukin-1\u03b2: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis. Neuropsychopharmacology 37:939\u2013949. https:\/\/doi.org\/10.1038\/npp.2011.277","journal-title":"Neuropsychopharmacology"},{"key":"8859_CR174","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1503\/jpn.100175","volume":"37","author":"M Holtze","year":"2012","unstructured":"Holtze M, Saetre P, Engberg G et al (2012) Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls. J Psychiatry Neurosci 37:53\u201357. https:\/\/doi.org\/10.1503\/jpn.100175","journal-title":"J Psychiatry Neurosci"},{"key":"8859_CR175","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1093\/schbul\/sbq112","volume":"37","author":"KV Sathyasaikumar","year":"2011","unstructured":"Sathyasaikumar KV, Stachowski EK, Wonodi I, Roberts RC, Rassoulpour A, McMahon RP, Schwarcz R (2011) Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia. Schizophr Bull 37:1147\u20131156. https:\/\/doi.org\/10.1093\/schbul\/sbq112","journal-title":"Schizophr Bull"},{"key":"8859_CR176","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/npp.2012.248","volume":"38","author":"S Erhardt","year":"2013","unstructured":"Erhardt S, Lim CK, Linderholm KR et al (2013) Connecting inflammation with glutamate agonism in suicidality. Neuropsychopharmacology 38:743\u2013752. https:\/\/doi.org\/10.1038\/npp.2012.248","journal-title":"Neuropsychopharmacology"},{"key":"8859_CR177","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.696059","author":"N Okamoto","year":"2021","unstructured":"Okamoto N, Natsuyama T, Igata R, Konishi Y, Tesen H, Ikenouchi A, Yoshimura R (2021) Associations between the kynurenine pathway, proinflammatory cytokines, and brain-derived neurotrophic factor in hospitalized patients with chronic schizophrenia: a preliminary study. Front Psychiatr. https:\/\/doi.org\/10.3389\/fpsyt.2021.696059","journal-title":"Front Psychiatr"},{"key":"8859_CR178","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.physbeh.2007.05.025","volume":"92","author":"S Erhardt","year":"2007","unstructured":"Erhardt S, Schwieler L, Nilsson L, Linderholm K, Engberg G (2007) The kynurenic acid hypothesis of schizophrenia. Physiol Behav 92:203\u2013209. https:\/\/doi.org\/10.1016\/j.physbeh.2007.05.025","journal-title":"Physiol Behav"},{"key":"8859_CR179","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1742-4658.2012.08551.x","volume":"279","author":"AM Myint","year":"2012","unstructured":"Myint AM (2012) Kynurenines: from the perspective of major psychiatric disorders. FEBS J 279:1375\u20131385. https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08551.x","journal-title":"FEBS J"},{"key":"8859_CR180","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/schbul\/sbq002","volume":"36","author":"I Wonodi","year":"2010","unstructured":"Wonodi I, Schwarcz R (2010) Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in Schizophrenia. Schizophr Bull 36:211\u2013218. https:\/\/doi.org\/10.1093\/schbul\/sbq002","journal-title":"Schizophr Bull"},{"key":"8859_CR181","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/s0140-6736(07)60750-8","volume":"369","author":"DC Baumgart","year":"2007","unstructured":"Baumgart DC, Carding SR (2007) Inflammatory bowel disease: cause and immunobiology. Lancet 369:1627\u20131640. https:\/\/doi.org\/10.1016\/s0140-6736(07)60750-8","journal-title":"Lancet"},{"key":"8859_CR182","doi-asserted-by":"publisher","first-page":"26","DOI":"10.5217\/ir.2018.16.1.26","volume":"16","author":"SH Lee","year":"2018","unstructured":"Lee SH, Kwon JE, Cho ML (2018) Immunological pathogenesis of inflammatory bowel disease. Intest Res 16:26\u201342. https:\/\/doi.org\/10.5217\/ir.2018.16.1.26","journal-title":"Intest Res"},{"key":"8859_CR183","doi-asserted-by":"publisher","first-page":"4280","DOI":"10.3748\/wjg.14.4280","volume":"14","author":"F Sanchez-Munoz","year":"2008","unstructured":"Sanchez-Munoz F, Dominguez-Lopez A, Yamamoto-Furusho JK (2008) Role of cytokines in inflammatory bowel disease. World J Gastroenterol 14:4280\u20134288. https:\/\/doi.org\/10.3748\/wjg.14.4280","journal-title":"World J Gastroenterol"},{"key":"8859_CR184","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1056\/NEJMe0811014","volume":"360","author":"CA Dinarello","year":"2009","unstructured":"Dinarello CA (2009) Interleukin-1beta and the autoinflammatory diseases. N Engl J Med 360:2467\u20132470. https:\/\/doi.org\/10.1056\/NEJMe0811014","journal-title":"N Engl J Med"},{"key":"8859_CR185","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1136\/gut.36.1.45","volume":"36","author":"K Mitsuyama","year":"1995","unstructured":"Mitsuyama K, Toyonaga A, Sasaki E et al (1995) Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6. Gut 36:45\u201349. https:\/\/doi.org\/10.1136\/gut.36.1.45","journal-title":"Gut"},{"key":"8859_CR186","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s0091-6749(99)70518-x","volume":"103","author":"CA Dinarello","year":"1999","unstructured":"Dinarello CA (1999) IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 103:11\u201324. https:\/\/doi.org\/10.1016\/s0091-6749(99)70518-x","journal-title":"J Allergy Clin Immunol"},{"key":"8859_CR187","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00535-010-0245-1","volume":"45","author":"A Kobori","year":"2010","unstructured":"Kobori A, Yagi Y, Imaeda H, Ban H, Bamba S, Tsujikawa T, Saito Y, Fujiyama Y, Andoh A (2010) Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J Gastroenterol 45:999\u20131007. https:\/\/doi.org\/10.1007\/s00535-010-0245-1","journal-title":"J Gastroenterol"},{"key":"8859_CR188","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00947","author":"J Milovanovic","year":"2020","unstructured":"Milovanovic J, Arsenijevic A, Stojanovic B, Kanjevac T, Arsenijevic D, Radosavljevic G, Milovanovic M, Arsenijevic N (2020) Interleukin-17 in chronic inflammatory neurological diseases. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.00947","journal-title":"Front Immunol"},{"key":"8859_CR189","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/ni.1736","volume":"10","author":"W O'Connor Jr","year":"2009","unstructured":"O\u2019Connor W Jr, Kamanaka M, Booth CJ, Town T, Nakae S, Iwakura Y, Kolls JK, Flavell RA (2009) A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat Immunol 10:603\u2013609. https:\/\/doi.org\/10.1038\/ni.1736","journal-title":"Nat Immunol"},{"key":"8859_CR190","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.clim.2004.05.004","volume":"113","author":"AM Wolf","year":"2004","unstructured":"Wolf AM, Wolf D, Rumpold H et al (2004) Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin Immunol 113:47\u201355. https:\/\/doi.org\/10.1016\/j.clim.2004.05.004","journal-title":"Clin Immunol"},{"key":"8859_CR191","doi-asserted-by":"publisher","first-page":"9706140","DOI":"10.1155\/2020\/9706140","volume":"2020","author":"X Ding","year":"2020","unstructured":"Ding X, Bin P, Wu W, Chang Y, Zhu G (2020) Tryptophan metabolism, regulatory T cells, and inflammatory bowel disease: a mini review. Mediators Inflamm 2020:9706140. https:\/\/doi.org\/10.1155\/2020\/9706140","journal-title":"Mediators Inflamm"},{"key":"8859_CR192","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.3389\/fimmu.2019.02565","volume":"10","author":"FJH Sorgdrager","year":"2019","unstructured":"Sorgdrager FJH, Naud\u00e9 PJW, Kema IP, Nollen EA, Deyn PP (2019) Tryptophan metabolism in inflammaging: from biomarker to therapeutic target. Front Immunol 10:2565. https:\/\/doi.org\/10.3389\/fimmu.2019.02565","journal-title":"Front Immunol"},{"key":"8859_CR193","doi-asserted-by":"publisher","first-page":"834","DOI":"10.15252\/msb.20156487","volume":"11","author":"A Mardinoglu","year":"2015","unstructured":"Mardinoglu A, Shoaie S, Bergentall M, Ghaffari P, Zhang C, Larsson E, B\u00e4ckhed F, Nielsen J (2015) The gut microbiota modulates host amino acid and glutathione metabolism in mice. Mol Syst Biol 11:834. https:\/\/doi.org\/10.15252\/msb.20156487","journal-title":"Mol Syst Biol"},{"key":"8859_CR194","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2014.07.027","volume":"277","author":"SM O'Mahony","year":"2015","unstructured":"O\u2019Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF (2015) Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res 277:32\u201348. https:\/\/doi.org\/10.1016\/j.bbr.2014.07.027","journal-title":"Behav Brain Res"},{"key":"8859_CR195","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/s1734-1140(11)70522-9","volume":"63","author":"J Dolecka","year":"2011","unstructured":"Dolecka J, Urbanik-Sypniewska T, Skrzyd\u0142o-Radoma\u0144ska B, Parada-Turska J (2011) Effect of kynurenic acid on the viability of probiotics in vitro. Pharmacol Rep 63:548\u2013551. https:\/\/doi.org\/10.1016\/s1734-1140(11)70522-9","journal-title":"Pharmacol Rep"},{"key":"8859_CR196","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.bbi.2019.02.009","volume":"79","author":"X Zheng","year":"2019","unstructured":"Zheng X, Hu M, Zang X et al (2019) Kynurenic acid\/GPR35 axis restricts NLRP3 inflammasome activation and exacerbates colitis in mice with social stress. Brain Behav Immun 79:244\u2013255. https:\/\/doi.org\/10.1016\/j.bbi.2019.02.009","journal-title":"Brain Behav Immun"},{"key":"8859_CR197","doi-asserted-by":"publisher","first-page":"8764","DOI":"10.3748\/wjg.v20.i27.8764","volume":"20","author":"G Casella","year":"2014","unstructured":"Casella G, Tontini GE, Bassotti G, Pastorelli L, Villanacci V, Spina L, Baldini V, Vecchi M (2014) Neurological disorders and inflammatory bowel diseases. World J Gastroenterol 20:8764\u20138782. https:\/\/doi.org\/10.3748\/wjg.v20.i27.8764","journal-title":"World J Gastroenterol"},{"key":"8859_CR198","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/ibd.21346","volume":"17","author":"W H\u00e4user","year":"2011","unstructured":"H\u00e4user W, Janke KH, Klump B, Hinz A (2011) Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. Inflamm Bowel Dis 17:621\u2013632. https:\/\/doi.org\/10.1002\/ibd.21346","journal-title":"Inflamm Bowel Dis"},{"key":"8859_CR199","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1053\/j.gastro.2005.06.022","volume":"129","author":"G Gupta","year":"2005","unstructured":"Gupta G, Gelfand JM, Lewis JD (2005) Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology 129:819\u2013826. https:\/\/doi.org\/10.1053\/j.gastro.2005.06.022","journal-title":"Gastroenterology"},{"key":"8859_CR200","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.cmet.2015.07.004","volume":"22","author":"S Metghalchi","year":"2015","unstructured":"Metghalchi S, Ponnuswamy P, Simon T et al (2015) Indoleamine 2,3-dioxygenase fine-tunes immune homeostasis in atherosclerosis and colitis through repression of interleukin-10 production. Cell Metab 22:460\u2013471. https:\/\/doi.org\/10.1016\/j.cmet.2015.07.004","journal-title":"Cell Metab"},{"key":"8859_CR201","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00210-011-0605-2","volume":"383","author":"Z Tiszlavicz","year":"2011","unstructured":"Tiszlavicz Z, N\u00e9meth B, F\u00fcl\u00f6p F, V\u00e9csei L, T\u00e1pai K, Ocsovszky I, M\u00e1ndi Y (2011) Different inhibitory effects of kynurenic acid and a novel kynurenic acid analogue on tumour necrosis factor-\u03b1 (TNF-\u03b1) production by mononuclear cells, HMGB1 production by monocytes and HNP1-3 secretion by neutrophils. Naunyn Schmiedebergs Arch Pharmacol 383:447\u2013455. https:\/\/doi.org\/10.1007\/s00210-011-0605-2","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"8859_CR202","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/s0306-4530(98)00040-7","volume":"24","author":"AV Ravindran","year":"1999","unstructured":"Ravindran AV, Griffiths J, Merali Z, Knott VJ, Anisman H (1999) Influence of acute tryptophan depletion on mood and immune measures in healthy males. Psychoneuroendocrinology 24:99\u2013113. https:\/\/doi.org\/10.1016\/s0306-4530(98)00040-7","journal-title":"Psychoneuroendocrinology"},{"key":"8859_CR203","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1586\/14737175.2015.1049999","volume":"15","author":"I Davis","year":"2015","unstructured":"Davis I, Liu A (2015) What is the tryptophan kynurenine pathway and why is it important to neurotherapeutics? Expert Rev Neurother 15:719\u2013721. https:\/\/doi.org\/10.1586\/14737175.2015.1049999","journal-title":"Expert Rev Neurother"},{"key":"8859_CR204","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","volume":"112","author":"R Schwarcz","year":"2017","unstructured":"Schwarcz R, Stone TW (2017) The kynurenine pathway and the brain: challenges, controversies and promises. Neuropharmacology 112:237\u2013247. https:\/\/doi.org\/10.1016\/j.neuropharm.2016.08.003","journal-title":"Neuropharmacology"},{"issue":"217\u2013225","key":"8859_CR205","doi-asserted-by":"publisher","first-page":"e268","DOI":"10.1111\/j.1365-2982.2009.01390.x","volume":"22","author":"G Varga","year":"2010","unstructured":"Varga G, Erces D, Fazekas B, F\u00fcl\u00f6p M, Kov\u00e1cs T, Kaszaki J, F\u00fcl\u00f6p F, V\u00e9csei L, Boros M (2010) N-Methyl-D-aspartate receptor antagonism decreases motility and inflammatory activation in the early phase of acute experimental colitis in the rat. Neurogastroenterol Motil 22(217\u2013225):e268. https:\/\/doi.org\/10.1111\/j.1365-2982.2009.01390.x","journal-title":"Neurogastroenterol Motil"},{"key":"8859_CR206","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1034\/k.1600-079x.2002.01881.x","volume":"32","author":"JR Calvo","year":"2002","unstructured":"Calvo JR, Guerrero JM, Osuna C, Molinero P, Carrillo-Vico A (2002) Melatonin triggers Crohn\u2019s disease symptoms. J Pineal Res 32:277\u2013278. https:\/\/doi.org\/10.1034\/k.1600-079x.2002.01881.x","journal-title":"J Pineal Res"},{"key":"8859_CR207","doi-asserted-by":"publisher","first-page":"e0142598","DOI":"10.1371\/journal.pone.0142598","volume":"10","author":"W Dabrowski","year":"2015","unstructured":"Dabrowski W, Kwiecien JM, Rola R et al (2015) Prolonged subdural infusion of kynurenic acid is associated with dose-dependent myelin damage in the rat spinal cord. PLoS ONE 10:e0142598. https:\/\/doi.org\/10.1371\/journal.pone.0142598","journal-title":"PLoS ONE"},{"key":"8859_CR208","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4137\/ijtr.s12536","volume":"6","author":"MP Turski","year":"2013","unstructured":"Turski MP, Turska M, Paluszkiewicz P, Parada-Turska J, Oxenkrug GF (2013) Kynurenic acid in the digestive system-new facts, new challenges. Int J Tryptophan Res 6:47\u201355. https:\/\/doi.org\/10.4137\/ijtr.s12536","journal-title":"Int J Tryptophan Res"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08859-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-023-08859-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-023-08859-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,25]],"date-time":"2023-11-25T12:03:29Z","timestamp":1700913809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-023-08859-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,18]]},"references-count":208,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["8859"],"URL":"https:\/\/doi.org\/10.1007\/s11033-023-08859-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,18]]},"assertion":[{"value":"12 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}